Neurocrine Biosciences (NBIX) Net Margin (2010 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Net Margin of 15.06% for Q2 2026, down 58.0% year-over-year from 35.85% in Q2 2025, and down 38.03% on a QoQ basis from 24.3% in Q1 2026.
Neurocrine Biosciences (NBIX) Net Margin (2010 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Net Margin for 16 years, with the latest figure at 15.06% in Q2 2026.
- Net Margin for Q2 2026 came in at 15.06%, down 58.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 20.91% (up 703.0% YoY), and the FY2025 annual result was 16.73%, up 224.0% from the prior year.
- Net Margin slipped to 15.06% in Q2 2026, from 24.3% in the prior quarter.
- Over five years, Net Margin peaked at 28.67% in Q4 2023 and troughed at 84.5% in Q2 2022.
- A 5-year average of 9.22% and a median of 16.54% in 2024 frame the typical range for Net Margin.
- The widest annual swing landed in 2022, when Net Margin slumped 9914 bps; it then soared 10560 bps in 2023.
- A 5-year view of Net Margin shows it stood at 21.6% in 2022, then surged by 33 bps to 28.67% in 2023, then tumbled by 43 bps to 16.43% in 2024, then climbed by 16 bps to 19.08% in 2025, then slipped by 21 bps to 15.06% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 15.06% in Q2 2026, 24.3% in Q1 2026, and 19.08% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 0.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.06% |
| Mar 31, 2026 | 24.30% |
| Dec 31, 2025 | 19.08% |
| Sep 30, 2025 | 26.36% |
| Jun 30, 2025 | 15.64% |
| Mar 31, 2025 | 1.38% |
| Dec 31, 2024 | 16.43% |
| Sep 30, 2024 | 20.86% |
| Jun 30, 2024 | 11.01% |
| Mar 31, 2024 | 8.42% |
| Dec 31, 2023 | 28.67% |
| Sep 30, 2023 | 16.66% |
| Jun 30, 2023 | 21.10% |
| Mar 31, 2023 | -18.22% |
| Dec 31, 2022 | 21.60% |
| Sep 30, 2022 | 17.66% |
| Jun 30, 2022 | -84.50% |
| Mar 31, 2022 | 4.48% |
| Dec 31, 2021 | -2.34% |
| Sep 30, 2021 | 7.60% |